These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 29589394)

  • 1. Combined Effects of Baicalein and Docetaxel on Apoptosis in 8505c Anaplastic Thyroid Cancer Cells via Downregulation of the ERK and Akt/mTOR Pathways.
    Park CH; Han SE; Nam-Goong IS; Kim YI; Kim ES
    Endocrinol Metab (Seoul); 2018 Mar; 33(1):121-132. PubMed ID: 29589394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer Effects of Baicalein in FRO Thyroid Cancer Cells Through the Up-regulation of ERK/p38 MAPK and Akt Pathway.
    Han SE; Park CH; Nam-Goong IS; Kim YI; Kim ES
    In Vivo; 2019; 33(2):375-382. PubMed ID: 30804115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100A4 Knockout Sensitizes Anaplastic Thyroid Carcinoma Cells Harboring BRAFV600E/Mt to Vemurafenib.
    Jiao X; Zhang H; Xu X; Yu Y; Zhang H; Zhang J; Ning L; Hao F; Liu X; Niu M; Chen CT; Chen D; Zhang K
    Cell Physiol Biochem; 2018; 49(3):1143-1162. PubMed ID: 30196299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer Effects of Ursi Fel Extract and Its Active Compound, Ursodeoxycholic Acid, in FRO Anaplastic Thyroid Cancer Cells.
    Jung HW; Hwang JH
    Molecules; 2021 Sep; 26(17):. PubMed ID: 34500742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin Enhances Docetaxel-Induced Apoptosis of 8505C Anaplastic Thyroid Carcinoma Cells.
    Hong JM; Park CS; Nam-Goong IS; Kim YS; Lee JC; Han MW; Choi JI; Kim YI; Kim ES
    Endocrinol Metab (Seoul); 2014 Mar; 29(1):54-61. PubMed ID: 24741455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combination of baicalin and baicalein enhances apoptosis via the ERK/p38 MAPK pathway in human breast cancer cells.
    Zhou QM; Wang S; Zhang H; Lu YY; Wang XF; Motoo Y; Su SB
    Acta Pharmacol Sin; 2009 Dec; 30(12):1648-58. PubMed ID: 19960010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The MEK1/2 Inhibitor AZD6244 Sensitizes BRAF-Mutant Thyroid Cancer to Vemurafenib.
    Song H; Zhang J; Ning L; Zhang H; Chen D; Jiao X; Zhang K
    Med Sci Monit; 2018 May; 24():3002-3010. PubMed ID: 29737325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baicalein induced apoptosis and autophagy of undifferentiated thyroid cancer cells by the ERK/PI3K/Akt pathway.
    Wang M; Qiu S; Qin J
    Am J Transl Res; 2019; 11(6):3341-3352. PubMed ID: 31312348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A-Kinase Interacting Protein 1 Knockdown Restores Chemosensitivity
    Zheng H; Lin Q; Rao Y
    Front Oncol; 2022; 12():854702. PubMed ID: 35965570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GANT61 suppresses cell survival, invasion and epithelial-mesenchymal transition through inactivating AKT/mTOR and JAK/STAT3 pathways in anaplastic thyroid carcinoma.
    Gao H; Wang W; Li Q
    Cancer Biol Ther; 2022 Dec; 23(1):369-377. PubMed ID: 35491899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential of the dual mTOR kinase inhibitor AZD2014 to overcome paclitaxel resistance in anaplastic thyroid carcinoma.
    Milošević Z; Banković J; Dinić J; Tsimplouli C; Sereti E; Dragoj M; Paunović V; Milovanović Z; Stepanović M; Tanić N; Dimas K; Pešić M
    Cell Oncol (Dordr); 2018 Aug; 41(4):409-426. PubMed ID: 29790111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of a histone deacetylase inhibitor (PXD101) for thyroid cancer treatment.
    Lin SF; Lin JD; Chou TC; Huang YY; Wong RJ
    PLoS One; 2013; 8(10):e77684. PubMed ID: 24155971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of smad2 and Erk/Akt cascade in TGF-β1-induced apoptosis in human gingival epithelial cells.
    Yoshimoto T; Fujita T; Kajiya M; Matsuda S; Ouhara K; Shiba H; Kurihara H
    Cytokine; 2015 Sep; 75(1):165-73. PubMed ID: 25882870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baicalein induces apoptosis and autophagy of breast cancer cells via inhibiting PI3K/AKT pathway in vivo and vitro.
    Yan W; Ma X; Zhao X; Zhang S
    Drug Des Devel Ther; 2018; 12():3961-3972. PubMed ID: 30510404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting TGF-β1 and AKT signal on growth and metastasis of anaplastic thyroid cancer cell in vivo.
    Li Y; Chen D; Hao FY; Zhang KJ
    Eur Rev Med Pharmacol Sci; 2016 Jun; 20(12):2581-7. PubMed ID: 27383308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dabrafenib and erlotinib combination treatment on anaplastic thyroid carcinoma.
    Choi YS; Kwon H; You MH; Kim TY; Kim WB; Shong YK; Jeon MJ; Kim WG
    Endocr Relat Cancer; 2022 May; 29(6):307-319. PubMed ID: 35343921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baicalein inhibits cell development, metastasis and EMT and induces apoptosis by regulating ERK signaling pathway in osteosarcoma.
    Lin H; Hao Y; Wan X; He J; Tong Y
    J Recept Signal Transduct Res; 2020 Feb; 40(1):49-57. PubMed ID: 31948366
    [No Abstract]   [Full Text] [Related]  

  • 18. Baicalein, an active component of Scutellaria baicalensis Georgi, prevents lysophosphatidylcholine-induced cardiac injury by reducing reactive oxygen species production, calcium overload and apoptosis via MAPK pathways.
    Chen HM; Hsu JH; Liou SF; Chen TJ; Chen LY; Chiu CC; Yeh JL
    BMC Complement Altern Med; 2014 Jul; 14():233. PubMed ID: 25012390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sunitinib exerts only limited effects on the proliferation and differentiation of anaplastic thyroid cancer cells.
    D'Agostino M; Voce P; Celano M; Sponziello M; Moretti S; Maggisano V; Verrienti A; Durante C; Filetti S; Puxeddu E; Russo D
    Thyroid; 2012 Feb; 22(2):138-44. PubMed ID: 22191389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effects of baicalein with gemcitabine or docetaxel on the proliferation, migration and apoptosis of pancreatic cancer cells.
    Liu P; Feng J; Sun M; Yuan W; Xiao R; Xiong J; Huang X; Xiong M; Chen W; Yu X; Sun Q; Zhao X; Zhang Q; Shao L
    Int J Oncol; 2017 Dec; 51(6):1878-1886. PubMed ID: 29039524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.